CEVA. Sponsor of ALIVE 2024

Together, beyond animal health

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.

With 6,700 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”.

Ceva is committed in the fight against parasites and zoonosis, such as Leishmaniosis, thanks to Advanced Solutions and Evidence Based Knowledge, under the “STRONGER TOGETHER Against Parasitic Diseases” initiatives.

Together, beyond animal health

Visit our Website

Contact Us

Ceva

For all general inquiries please contact Ceva here.

Ceva Santé Animale

TURQUOISE Sponsor ALIVE 2, 2024

by Pilar Vidueira

ALIVE 2 - Gala Dinner

Gala Dinner
Musée national Marc Chagall,
Nice, France

Join us for an unforgettable evening at the Chagall Museum in Nice!

We are delighted to confirm that ALIVE’s Gala Dinner will take place in this amazing venue.
An inspiring environment to network with fellow experts, to exchange knowledge and enjoy a superb dinner whilst admiring the art of Marc Chagall, one of the most influential artists of the 20th century.

We look forward to sharing with you this unique experience!

Number of attendees is limited. Please make sure you register soon to avoid disappointment.
Transportation will be provided from/to the congress venue.

Musée national Marc Chagall
Avenue du Docteur Ménard
Nice 06000

T | (33) 4 9353 8720
W | More information

Open every day except Tuesdays from 10:00 am to 5:00 pm

by Pilar Vidueira

LETI Pharma. Sponsor of ALIVE 2024

Innovative Solutions for Health and Wellbeing

LETI Pharma is a company with a global presence of reference in specialized segments of health and wellness, a leader through innovation and development of prestige products and brands.

LetiFend®: vaccine against canine Leishmaniasis

LetiFend® is the first vaccine against canine Leishmaniasis developed in Europe with a chimeric protein and it provides veterinarians with a totally safe tool.

Animal Health

Visit our Website

Contact Us

LETI Pharma

For all general inquiries please contact LETI Pharma here.

LETI Pharma

RUBY Sponsor ALIVE 2, 2024

by Pilar Vidueira

ALIVE 2, 2024 RUBY Sponsors

ALIVE 2, 2024 SAPPHIRE Sponsors

ALIVE 2, 2024 TURQUOISE Sponsors

Boehringer Ingelheim, proud sponsors of ALIVE 2, 2024

ALIVE 2, 2024 DONORS

LeishVet Sponsors

by Pilar Vidueira

Media Kit

Please spread the word about our Event, ALIVE 2024 – Animal Leishmaniosis International Veterinary Event, to your community. Feel free to use the images and text below to compose an email or social media post.

Event Information

ALIVE 2024, Animal Leishmaniosis International Veterinary Event
A presential and online event, bringing together the latest clinical practices and research material on animal leishmaniosis
April 18th – 20th, 2024
Venue: Radisson Blu, Nice, France
www.leishvet-alive.com

Look at the ProgramRegistration

Images

Please download them here. Scale changes are permitted, but all other modifications are prohibited. If you need a specific size, contact social@leishvet-alive.com

Download Logo

Press Releases

Download Press Release in English
Download Press Release in French
Download Press Release in Spanish
Download Press Release in Portuguese
Download Press Release in Italian
Download Press Release in German

Suggested Marketing Language

Don’t miss ALIVE 2024: Organized by LeishVet and taking place in Nice, France. A presential and online event that will bring together the latest worldwide clinical practices and research material on animal leishmaniosis.

Social Media

Include the following hashtags in your social media posts:
#ALIVE2024
#LeishvetALIVE
#leishmaniosis
#leishmaniasis
#leishmania
#LeishVet

Follow LeishVet ALIVE on Facebook and Instagram to receive conference updates.

Suggested Media Posts
Interested in #leishmaniosis #leishmania? Attend #LeishvetALIVE April 18-20, 2024, in Nice, France. Registration is now OPEN. Presential and Online formats leishvet-alive.com

Come network & learn, see what’s new in #leishmaniosis at #ALIVE2024 April 18-20, 2024, in Nice, France. Leishvet-alive.com

#ALIVE2024 is bringing you the largest gathering of clinicians and researchers working on #leishmaniosis and #leishmania worldwide – Online and Presential formats! April 18-20, 2024, in Nice, France, leishvet-alive.com

Branding

LeishVet is a scientific association founded in 2005 by veterinarians from academic institutions of different countries focusing their research and clinical activity on leishmaniosis in veterinary medicine. Their Fact Sheets on Leishmaniosis have been accessed more than 160,000 times. LeishVet is officially registered in Spain at the National Register of Associations for non-profit effects. Learn more at leishvet.org

by Pilar Vidueira

Scientific Committee

Scientific Committee ALIVE 2024

Assuring high quality content

Alcover Amengual, Maria Madgdalena - Universitat de Barcelona - UB (Spain)
Baneth, Gad – Hebrew University of Jerusalem (Israel)
Berriatúa, Eduardo – Universidad de Murcia (Spain)
Bourdeau, Patrick – École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique (France)
Brovida, Claudio – CBR – Ospedale Veterinario Anubi (Italy)
Cardoso, Luis – Universidade de Trás-os-Montes e Alto Douro (Portugal)
Cerón, José – Universidad de Murcia (Spain)
Courtenay, Orin – University of Warwick (United Kingdom)
Cruz, Israel – Instituto de Salud Carlos III (Spain)
Dantas-Torres, Filipe – Oswaldo Cruz Foundation (Brazil)
Fernandez-Prada, Christopher – Université de Montréal (Canada)
Ferrer, Lluis – Universitat Autònoma de Barcelona - UAB (Spain)
Ferroglio, Ezio – Università degli Studi di Torino (Italy)
Foglia Manzillo, Valentina – Università degli Studi di Napoli Federico II (Italy)
Fondati, Alessandra – Veterinaria Cetego, Rome - Clinica Veterinaria Colombo, Lido di Camaiore (Italy)
Gálvez, Rosa – Universidad Autónoma de Madrid (Spain)
Hartmann, Katrin – Ludwig-Maximilians-Universität München (Germany)
Kamhawi, Shaden – NIAID, National Institute of Allergy and Infectious Diseases (US)
Leiva, Marta – Universitat Autònoma de Barcelona - UAB (Spain)
Maia, Carla – Instituto de Higiene e Medicina Tropical - Universidade NOVA de Lisboa (Portugal)
Martínez-Orellana, Pamela – International Centre for Genetic Engineering and Biotechnology-ICGEB (Italy)
Marty, Pierre – Faculté de Médecine de l’Université Côte d’Azur, Nice (France)
Miró, Guadalupe – Universidad Complutense de Madrid (Spain)
Montoya, Ana – Universidad Complutense de Madrid (Spain)
Nogueira dos Santos, Fábio – BRASILEISH (Brazil)
Oliva, Gaetano – Università degli Studi di Napoli Federico II (Italy)
Oliveira, Rodolfo – Universidade de Lisboa (Portugal)
Otranto, Domenico – Università degli studi di Bari Aldo Moro (Italy)
Ordeix, Laura – Universitat Autònoma de Barcelona - UAB (Spain)
Papadopoulos, Elias – Aristotle University of Thessaloniki (Greece)
Pennisi, Maria Grazia – Università degli Studi di Messina (Italy)
Saridomichelakis, Manolis – University of Thessaly (Greece)
Shaw, Jeffrey – São Paulo University (Brazil)
Solano Gallego, Laia – Universitat Autònoma de Barcelona - UAB (Spain)
Spaëth, Gérald – Pasteur Institute (France)
Tabanez, Paulo – BRASILEISH (Brazil)
Töz, Seray – Ege Üniversitesi (Turkey)
Vitale, Fabrizio – Istituto Zooprofilattico Sperimentale della Sicilia (Italy)

This list is provisional, awaiting for other confirmations.

by Pilar Vidueira

Scientific Programme - Alive 2, 2024

Scientific Program

Please find below the provisional program for ALIVE 2, 2024

Thursday 18^th April, 2024

	Arrival in the afternoon
19:30 - 22:30	Welcome Cocktail at the Rooftop of the Radisson Blu

Friday 19^th April, 2024

	Research Stream	Clinical Stream
08:30 - 09:00	Opening Ceremony
09:00 - 09:45	Plenary Session \| Jorge Alvar Control of visceral leishmaniasis: successes, risks and expectations Read more
10:00 - 10:45	Session 1: “Around the vectors” Oral Communications	Keynote Speaker - Marta Leiva Top three ophthalmic challenges in the management of animal leishmaniosis Read more
10:45 - 11:30	Coffee-Break \| Poster Session \| Commercial Exhibition
11:30 - 12:15	Keynote Speaker - Carla Maia Phlebotomine sand flies – small vectors causing major problems in public and animal health Read more	Session 2: "Evaluation in the fields" Oral Communications
12:15 - 12:30	Session 1 cont.: “Around the vectors” Oral Communications	Session 2: "Evaluation in the fields" Oral Communications
12:30 - 13:15	Round Table Vectorial and non-vectorial transmission	Round Table The post-treatment management of leishmaniosis (endemic and non-endemic areas)
13:15 - 14:15	Lunch
14:15 - 15:00	Session 3: "Prospective for control" Oral Communications	Keynote Speaker - Chiara Noli Expect the unexpected: usual and unusual skin lesions in canine leishmaniosis Read more
15:00 - 15:15	Session 3: "Prospective for control" Oral Communications	Session 4: "Immune response, consequences" Oral Communications
15:15 - 16:00	Keynote Speaker - Christopher Fernandez-Prada Extracellular vesicles and canine leishmaniosis: friends or foes? Read more
16:00 - 16:45	Coffee-Break \| Poster Session \| Commercial Exhibition
16:45 - 17:30	Session 3 cont.: “Prospective for control” Oral Communications	Session 4 cont.: “Immune response, consequences” Oral Communications
17:30 - 18:15	Round Table Drug resistance	Round Table Leishmaniosis and immune mediated diseases: diagnostic and therapeutic challenges
19:15	Bus departure for Gala Dinner at the Chagall Museum

Saturday 20^th April, 2024

	Research Stream	Clinical Stream
08:00 - 08:45	Informal Get Together (young scientists and clinicians breakfast with LeishVet group)
09:00 - 09:45	Session 5: "Epidemiology: around the Leishmanias" Oral Communications	Keynote Speaker - Manolis Saridomichelakis When should clinicians suspect feline leishmaniosis? Read more
09:45 - 10:00		Session 6: "Monitoring" Oral Communications
10:00 - 10:45	Keynote Speaker - Christine Petersen Dogma, ecology, and potential reservoirs for Leishmania donovani in Bihar, India Read more	Session 6: "Monitoring" Oral Communications
10:45 - 11:30	Coffee-Break \| Poster Session \| Commercial Exhibition
11:30 - 12:15	Session 5 cont.: "Epidemiology: around the Leishmanias" Oral Communications	Session 6 cont.: "Monitoring" Oral Communications
12:15 - 13:00	Round Table Leishmaniases: many diseases, One Health	Round Table Coinfections
13:00 - 14:00	Lunch
14:00 - 14:45	Session 7: "One Health" Oral Communications	Keynote Speaker - Lluís Ferrer The conundrum of clinical relapses in canine leishmaniosis Read more
14:45 - 15:00	Session 7: "One Health" Oral Communications	Session 8: "Diagnosis" Oral Communications
15:00 - 15:45	Keynote Speaker - Filipe Dantas-Torres Other Leishmania species infecting dogs: zoonotic and clinical significance Read more	Session 8: "Diagnosis" Oral Communications
15:45 - 16:30	Coffee-Break \| Poster Session \| Commercial Exhibition
16:30 - 17:00	Session 7 cont.: "One Health" Oral Communications	Session 8 cont.: "Diagnosis" Oral Communications
17:00 - 17:30	Closing Ceremony

by Pilar Vidueira

Speakers ALIVE 2024

Meet the Speakers

Sharing their worldwide knowledge and experience

Keynote Speaker

Dr Jorge Alvar

Opening Ceremony

Lecture

Control of visceral leishmaniasis: successes, risks and expectations

Keynote Speaker

Dr Lluís Ferrer

Lecture

The conundrum of clinical relapses in canine leishmaniosis

Keynote Speaker

Dr Marta Leiva

Lecture

Top three ophthalmic challenges in the management of animal leishmaniosis

Keynote Speaker

Dr Chiara Noli

Lecture

Expect the unexpected: usual and unusual skin lesions in canine leishmaniosis

Dr M. Saridomichelakis, Speaker at ALIVE 2024

Keynote Speaker

Dr Manolis Saridomichelakis

Lecture

When should clinicians suspect feline leishmaniosis?

Keynote Speaker

Dr Filipe Dantas-Torres

Lecture

Other Leishmania species infecting in dogs: zoonotic and clinical significance

Keynote Speaker

Dr Christopher Fernandez-Prada

Lecture

Extracellular vesicles and canine leishmaniosis: friends or foes?

Keynote Speaker

Dr Carla Maia

Lecture

Phlebotomine sand flies – small vectors causing major problems in public and animal health

Keynote Speaker

Dr Christine Petersen

Lecture

Dogma, ecology, and potential reservoirs for Leishmania donovani in Bihar, India

by Pilar Vidueira

Alive 2024 @ Nice

by Pilar Vidueira

Welcome to Alive 2024

Thank you all for
making ALIVE 2
a great success

Welcome to Alive 2, 2024

A presential and online event, bringing together the latest clinical practices and research material on animal leishmaniosis

SAVE THE DATE | 18-20 April, 2024

If you want to keep up with the latest news about the event or participate in a more active way, please fill in your details below.

000 days 00 hours 00 minutes 00 seconds

We are looking forward to seeing you in Nice!

— Questions? Get in touch @contact

Alive 2, 2024

An International Congress on Animal Leishmaniosis

SAVE THE DATE | 18-20 APRIL, 2024

Organized by:

LeishVet Sponsors:

These are our goals:

To share novel research and discoveries on leishmaniosis and to provide a setting to exchange ideas from attendees worldwide.
To open a forum for individuals and organizations in both public and private sectors (One Health professionals: veterinarians, physicians, biologists, public health authorities).
To promote multi-disciplinary interactions from basic research to translational clinical or environmental settings.
To promote a place for deep discussions on solving the problems of animal leishmaniosis.
To foster international collaboration, industrial participation and training for One Health professionals.

Two streams will be organized:

Clinical practice oriented stream
Research oriented stream

ALIVE congress topics will include the following subjects from companion animals to wildlife:

Epidemiology: vectorial and non-vectorial transmission, Leishmania geographic distribution, infectiousness, etc.
Basic to clinical immunology.
Genomics, transcriptomics, proteomics and metabolomics of leishmaniosis, susceptibility and resistance to infection and disease.
Pathogenesis.
Clinical and diagnostic aspects.
Treatment, prognosis and monitoring: old and new treatments, drug resistance, drug development, immunotherapy, new monitoring and prognostic tests.
Preventative tools: targeting phlebotomine sand flies, host immune response (vaccines, immunomodulators), etc.